Generalized convulsions due to sorafenib-induced hypocalcemia.
Cholongitas
Evangelos
E
Georgousaki
Chrysa
C
Spyrou
Simos
S
Dasenaki
Maria
M
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001557:Benzenesulfonates / Q000009:adverse effects*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced* / Q000150:complications*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000009:adverse effects*; D012640:Seizures / Q000209:etiology*; D000077157:Sorafenib; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib